Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

The authors reply to: “Doubts about first report of krokodil use in Canada”

Feras M. Ghazawi and Jennifer Beecker
CMAJ January 06, 2020 192 (1) E16; DOI: https://doi.org/10.1503/cmaj.74079
Feras M. Ghazawi
Resident physician in dermatology, Division of Dermatology, University of Ottawa, Ottawa, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Beecker
Dermatologist, Division of Dermatology, University of Ottawa, Ottawa, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

We agree with Dr. Mitchell’s1 comment on our case report that critique is a part of the scientific process. To elaborate on our brief report,2 the patient was referred to the academic dermatology service for a presumptive diagnosis of pyoderma gangrenosum. Despite the clinical presentation of the ulcers not being classic for pyoderma gangrenosum, the patient was treated aggressively for this condition in hospital with high-dose steroids for more than a month, antibiotics, and increasing doses of cyclosporine as a steroid-sparing agent, as well as intensive wound care. No substantial improvement occurred in this patient with this aggressive treatment, and the small improvements that were seen were most likely due to secondary infection responding to the antibiotics. The disease course was clearly not typical of pyoderma gangrenosum as a decreased ulcer size within 1 month of starting immunosuppressive medications was expected (a diagnostic criterion of pyoderma gangrenosum).3

Several experienced academic dermatologists reviewed the case. Additional collateral information was volunteered that suggested that the patient had a history of injection drug use and had injected himself with krokodil (desomorphine). With this new information, and careful review of the morphology of published reports on ulcers caused by use of krokodil, it was clear that the unusual blackish scale and necrotic morphology of the ulcers in this patient were pathognomonic of krokodil use. Our patient improved when pyoderma gangrenosum–focused treatment was withdrawn. On recent follow-up with this patient, his wounds remained healed without therapy, which is also atypical of pyoderma gangrenosum.

While not commonly used, krokodil is a cheaper and more accessible drug than heroin;4 it can be made at home using easily obtainable ingredients. Its low cost and high potency (10 times more potent than morphine) may mean that it will be used more commonly in the future.3

This case is noteworthy for several reasons. First, a thorough clinical and collateral history is of utmost importance; second, it is imperative to avoid anchoring bias to a diagnosis and physicians must generate a wide-differential diagnosis, particularly when a disease fails to improve as expected on treatment; and, lastly, morphology and visual diagnostic skills are key to accurately diagnosing dermatologic conditions.

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Mitchell IV
    . Doubts about first report of krokodil use in Canada [letter]. CMAJ 2019;191:E1033.
    OpenUrlFREE Full Text
  2. ↵
    1. Ghazawi FM,
    2. Beecker J
    . Necrotic leg ulcers associated with krokodil injection in a 41-year-old man. CMAJ 2019;191:E712.
    OpenUrlFREE Full Text
  3. ↵
    1. Maverakis E,
    2. Ma C,
    3. Shinkai K,
    4. et al
    . Diagnostic criteria of ulcerative pyoderma gangrenosum: a delphi consensus of international experts. JAMA Dermatol 2018;154:461–6.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Shelton M,
    2. Ramirez-Fort MK,
    3. Lee KC,
    4. et al
    . Krokodil: from Russia with love. JAMA Dermatol 2015;151:32.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (1)
CMAJ
Vol. 192, Issue 1
6 Jan 2020
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The authors reply to: “Doubts about first report of krokodil use in Canada”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The authors reply to: “Doubts about first report of krokodil use in Canada”
Feras M. Ghazawi, Jennifer Beecker
CMAJ Jan 2020, 192 (1) E16; DOI: 10.1503/cmaj.74079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The authors reply to: “Doubts about first report of krokodil use in Canada”
Feras M. Ghazawi, Jennifer Beecker
CMAJ Jan 2020, 192 (1) E16; DOI: 10.1503/cmaj.74079
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Doubts about first report of krokodil use in Canada
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Using pathology data to evaluate surgical backlogs: considerations for resource planning
  • Using bar codes to create a robust national vaccine registry
  • Building research infrastructure across a health service
Show more Letters

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire